The World’s First Real Nitric Oxide Containing Super-Molecule Supplement
Nitric oxide is involved in several processes in the human body during intense weight training and muscle building exercises. The most noteworthy role is in the dilation of blood vessels to help achieve the maximum “muscle pump” during workouts. With the development of eNOXIDE, MuscleMeds has changed the paradigm of f nitric oxide supplementation with the world’s first and only Nitric Oxide Super-Molecule supplement – 2-(nitrooxy)ethyl 2-amino-3-methylbutanoate. eNOXIDE is so unique that it has been awarded a U.S. Patent!
eNOXIDE is a revolutionary breakthrough in nitric oxide (NO) supplementation made possible through the development of a biomedically engineered REAL nitric oxide containing molecule. Unlike Arginine, AAKG or citrulline, which must go through the complex biochemical pathway to produce NO, eNOXIDE is easily metabolized to release NO into the body. eNoxide is NOT a nitric oxide precursor – eNOXIDE contains bound nitric oxide. Administered in an advanced FastSorb delivery system, eNOXIDE is designed to deliver actual exogenous NO molecules into the bloodstream.
eNOXIDE is in a class of its own – it’s a biomedically engineered nitric oxide super-molecule designed to deliver real NO to the bloodstream to support pumps and your muscle building efforts.
eNOXIDE – Patented Nitric Oxide Containing Super Molecule!
Scientific Evidence that Precursors like Arginine and AAKG May Yield Limited Nitric Oxide Output Leads to the Discovery of a new Nitric Oxide Super-Molecule.
In the development of eNOXIDE, researchers undertook an extensive review and evaluation of the nitric oxide (NO) precursor and stimulating ingredients used in many products and numerous Nitric Oxide research studies to determine a potential new way for boosting NO levels. After extensive review, scientists discovered that the typical NO precursor and NO stimulating ingredients may only have minimal effects in elevating NO in the bloodstream, with individual effectiveness results varying. Research indicates the dose-response limitations of using orally administered arginine or other arginine based compounds, such as Arginine, Arginine Alpha-Ketoglutarate (AAKG), Citrulline and other NO precursors and stimulators. For example, when reviewing the research conducted using arginine, it was found that in order to achieve significant elevation of NO, very large dosages of arginine (as much as 30 grams) were required, and that was using intravenous (IV) administration. Research also revealed that the oral dosage methods used by all supplements (capsules, tablets, powder mixes, liquid drinks, etc.) were likely much less effective compared to IV administration (approximately 1/10th the researched dosage).
In light of the gap that existed between the research realities of requiring very high dosages of various administrations of arginine and the low dosages found being used among many products in the marketplace, exploration of effective ways of increasing NO levels in the bloodstream was warranted. This research effort culminated in the development of the new class of supplemental Nitric Oxide Super-Molecules contained in eNOXIDE.
The Development of the World’s First
Real Nitric Oxide Super-Molecule
Unlike conventional NO products that merely attempt to increase NO levels using precursor ingredients such as Arginine, AAKG or Citrulline, which must go through the complex biochemical pathway to potentially produce only limited amounts of NO, eNOXIDE is designed to contain a real NO functional group linked to a natural carrier molecule and utilizes natural enzymatic hydrolysis in the body to deliver nitric oxide into the bloodstream. eNOXIDE is designed to work rapidly and deliver real Nitric Oxide (NO) into the bloodstream. In pre-clinical and clinical research, eNoxide was shown to increase in circulation nitrate/nitrite, an important marker for increased pumps.
FastSorb Sub-buccal Delivery
FastSorb liposome carrier tablet technology to help achieve rapid uptake, designed for improving bioavailability and NO boosting efficacy.
To achieve stability and delivery system goals, eNOXIDE utilizes a novel dual functional liposomal delivery system. The FastSorb liposomal-based technology helps to stabilize the bioactive NO super molecule and upon administration is designed for rapid and absorption into the bloodstream
eNOXIDE sub-buccal oral administration FastSorb tablets contain a patented proprietary Nitric Oxide Super-Molecule: 2-(nitrooxy)ethyl 2-amino-3-methylbutanoate, a valine (BCAA) ethyl ester.
The eNOXIDE molecular structure is: